Scout | Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)

This grant opportunity seeks applications to develop and conduct clinical trials for treatments addressing cognitive and neuropsychiatric changes related to aging, Alzheimer's disease, and related dementias. It covers trials for both drug and non-drug interventions at various disease stages, from pre-symptomatic to severe. The grant also aims to encourage research on improving trial design and…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Opportunity Released: December 23, 2022

Open for Submission: December 23, 2022

Submission Deadline: January 7, 2025

Application Window Closes: January 7, 2025

Keywords

Alzheimer's Disease

Cognitive Decline

Clinical Trials

Pharmacological Interventions

Non-Pharmacological Interventions

Neuropsychiatric Changes

Age-Related Dementias

Alzheimer's Research

Trial Design

Dementia Spectrum

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers